Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morinda officinalis oligosaccharide capsules for vascular depression
ChiCTR2100049044Phase 4Not yet recruiting
- Sponsor
- Beijing University of Chinese Medicine East Hospital
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in vascular depression (VD) comparing Morinda officinalis oligosaccharide capsule group with Placebo group (2 arms). Primary endpoint: Hamilton Depression Scale 17. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
morinda officinalis oligosaccharide
03
Conditions
vascular depression (VD)
Beyond the preview
Go deeper on ChiCTR2100049044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049044.